Keyphrases
Cystic Fibrosis
80%
Pulmonary Exacerbation
36%
AE-IPF
18%
Standardized Treatment
15%
Forced Expiratory Volume in 1 Second (FEV1)
11%
Cystic Fibrosis Foundation
11%
C-reactive Protein
7%
Treatment Response
6%
Lung Function
6%
F508del
6%
Pediatric
6%
Acute Pulmonary Exacerbation
6%
Treatment Duration
6%
Cystic Fibrosis Transmembrane Conductance Regulator
6%
Sex Differences
5%
Clinician Practices
5%
Lumacaftor-ivacaftor
5%
Antimicrobial Duration
5%
Reproductive Health Services
5%
Sexual Health
5%
Clinical Outcomes
5%
IV Antibiotics
5%
Confidence Interval
5%
Symptom Score
5%
Medicine and Dentistry
Cystic Fibrosis
100%
Symptom
20%
Cystic Fibrosis Transmembrane Conductance Regulator
14%
Patient with Cystic Fibrosis
14%
Reproductive Public Health
9%
Antibiotics
8%
Ivacaftor
8%
Clinician
8%
C Reactive Protein
8%
Antibiotic Therapy
8%
Treatment Response
7%
Mucus
7%
Lung Transplantation
7%
Lumacaftor
6%
Hemoptysis
6%
Sex Difference
5%
Reproductive Medicine
5%
COVID-19
5%
Observational Study
5%
Respiratory Tract Infection
5%
Disease
5%
Tezacaftor
5%
Treatment Duration
5%